Media stories about NanoString Technologies (NASDAQ:NSTG) have been trending somewhat positive on Wednesday, Accern reports. The research firm identifies positive and negative news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. NanoString Technologies earned a coverage optimism score of 0.02 on Accern’s scale. Accern also assigned news stories about the biotechnology company an impact score of 46.5131547925683 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
A number of equities analysts have weighed in on NSTG shares. Morgan Stanley restated an “equal weight” rating and issued a $12.00 price target (down previously from $13.00) on shares of NanoString Technologies in a report on Thursday, March 8th. Zacks Investment Research upgraded NanoString Technologies from a “hold” rating to a “buy” rating and set a $11.00 price target for the company in a report on Wednesday, May 9th. ValuEngine upgraded NanoString Technologies from a “strong sell” rating to a “sell” rating in a report on Wednesday, May 9th. BidaskClub upgraded NanoString Technologies from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 19th. Finally, Robert W. Baird upped their target price on NanoString Technologies from $13.00 to $15.00 and gave the company an “outperform” rating in a research report on Monday, June 4th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $14.50.
Shares of NanoString Technologies traded down $0.36, reaching $13.96, during trading on Wednesday, according to MarketBeat. The company’s stock had a trading volume of 2,648 shares, compared to its average volume of 182,615. NanoString Technologies has a twelve month low of $5.87 and a twelve month high of $16.83. The firm has a market cap of $359.23 million, a price-to-earnings ratio of -7.61 and a beta of 0.81. The company has a quick ratio of 2.67, a current ratio of 3.29 and a debt-to-equity ratio of 1.97.
NanoString Technologies (NASDAQ:NSTG) last announced its earnings results on Tuesday, May 8th. The biotechnology company reported ($0.75) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.76) by $0.01. NanoString Technologies had a negative return on equity of 108.29% and a negative net margin of 36.62%. The company had revenue of $23.09 million for the quarter, compared to analyst estimates of $21.48 million. equities analysts expect that NanoString Technologies will post -2.77 earnings per share for the current fiscal year.
NanoString Technologies Company Profile
NanoString Technologies, Inc provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files.
Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.